Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer
Another approach to targeting aberrant sphingolipid metabolism is to inhibit glycosphingolipid synthesis in cancer cells with eliglustat, which is used in the treatment of Gaucher disease and shown to suppress the growth of prostate cancer xenografts.22 S1P synthesis can be inhibited with sphingosine
Another approach to targeting aberrant sphingolipid metabolism is to inhibit glycosphingolipid synthesis in cancer cells with eliglustat, which is used in the treatment of Gaucher disease and shown to suppress the growth of prostate cancer xenografts.22 S1P synthesis can be inhibited with sphingosine
